ARTICLE | Company News
Alfacell cancer news
September 22, 2008 7:00 AM UTC
Alfacell retained Oppenheimer & Co. to explore strategic alternatives, including partnerships or a possible sale of the company. Alfacell's lead candidate is Onconase ranpirnase. The company expects ...